Role of nitric oxide in angiogenesis and microcirculation in tumors

[1]  T. Sugimura,et al.  Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. , 1997, Cancer research.

[2]  I. Fidler,et al.  Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene. , 1997, Journal of the National Cancer Institute.

[3]  G. Tozer,et al.  Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. , 1997, Cancer research.

[4]  R. Jain,et al.  Effect of tumor necrosis factor alpha on vascular resistance, nitric oxide production, and glucose and oxygen consumption in perfused tissue-isolated human melanoma xenografts. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  R. Jain,et al.  Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. , 1997, The American journal of pathology.

[6]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[7]  G. Rosner,et al.  Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure. , 1997, Radiation research.

[8]  W. Zapol,et al.  Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. , 1996, The American journal of physiology.

[9]  M. Stratford,et al.  Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification. , 1996, British Journal of Cancer.

[10]  H. Granger,et al.  VEGF induces NO-dependent hyperpermeability in coronary venules. , 1996, The American journal of physiology.

[11]  R. Hobson,et al.  Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury. , 1996, Microvascular research.

[12]  K. Black,et al.  Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. , 1996, Cancer research.

[13]  R K Jain,et al.  Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. , 1996, The American journal of pathology.

[14]  H. Saito,et al.  Role in nitric oxide in Kupffer cell–mediated hepatoma cell cytotoxicity in vitro and ex vivo , 1996, Hepatology.

[15]  R. Jain,et al.  Leukocyte-endothelial adhesion and angiogenesis in tumors , 1996, Cancer and Metastasis Reviews.

[16]  H. Maeda,et al.  Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth , 1996, Cancer.

[17]  P. K. Lala,et al.  NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. , 1996, British Journal of Cancer.

[18]  R. Jain,et al.  Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. , 1995, Cancer research.

[19]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[20]  P. Kubes.  Nitric Oxide Affects Microvascular Permeability in the Intact and Inflamed Vasculature , 1995, Microcirculation.

[21]  W. Durán,et al.  Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. , 1995, Microvascular research.

[22]  G. Karakiulakis,et al.  Inhibition of angiogenesis, tumour growth and metastasis by the NO‐releasing vasodilators, isosorbide mononitrate and dinitrate , 1995, British journal of pharmacology.

[23]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[24]  Richard Graham Knowles,et al.  Nitric oxide synthase activity in human breast cancer. , 1995, British Journal of Cancer.

[25]  M. Dewhirst,et al.  Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. , 1995, British Journal of Cancer.

[26]  C. Nathan,et al.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.

[27]  P Rhodes,et al.  Roles of nitric oxide in tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[29]  P. Barnes.  Cyclic nucleotides and phosphodiesterases and airway function. , 1995, The European respiratory journal.

[30]  K. Aldape,et al.  Expression of nitric oxide synthase in human central nervous system tumors. , 1995, Cancer research.

[31]  C. Thiemermann,et al.  Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine. , 1994, Cancer research.

[32]  S Amerini,et al.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.

[33]  L. Ellis,et al.  The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.

[34]  Y. Uchida,et al.  Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

[35]  A. M. Lefer,et al.  Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. , 1994, Gastroenterology.

[36]  U. Walter,et al.  NO at work , 1994, Cell.

[37]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[38]  R K Jain,et al.  Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.

[39]  A. Koch,et al.  Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Maeda,et al.  Enhanced Vascular Permeability in Solid Tumor Is Mediated by Nitric Oxide and Inhibited by Both New Nitric Oxide Scavenger and Nitric Oxide Synthase Inhibitor , 1994, Japanese journal of cancer research : Gann.

[41]  P. Peristeris,et al.  Evidence that nitric oxide is an endogenous antiangiogenic mediator , 1994, British journal of pharmacology.

[42]  Richard Graham Knowles,et al.  Nitric oxide synthase activity in human gynecological cancer. , 1994, Cancer research.

[43]  S. Snyder,et al.  Targeted disruption of the neuronal nitric oxide synthase gene , 1993, Cell.

[44]  Xin-Yun Huang,et al.  Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor , 1993, Cell.

[45]  L. Buttery,et al.  Induction of nitric oxide synthase in the neo‐vasculature of experimental tumours in mice , 1993, The Journal of pathology.

[46]  J. Filep,et al.  Modulation by nitric oxide of platelet‐activating factor‐induced albumin extravasation in the conscious rat , 1993, British journal of pharmacology.

[47]  S. Moncada,et al.  The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat , 1993, British journal of pharmacology.

[48]  H. Granger,et al.  Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. , 1993, Biochemical and biophysical research communications.

[49]  R. Jain,et al.  Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. , 1993, Microvascular research.

[50]  H. Granger,et al.  Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. , 1993, The American journal of physiology.

[51]  M. Maragoudakis,et al.  Nitric oxide is involved in the regulation of angiogenesis , 1993, British journal of pharmacology.

[52]  I. Hart,et al.  Inhibitors of nitric oxide synthase selectively reduce flow in tumour‐associated neovasculature , 1992, British journal of pharmacology.

[53]  S. Moncada.  The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. , 1992, Acta physiologica Scandinavica.

[54]  P. Kubes,et al.  Nitric oxide modulates microvascular permeability. , 1992, The American journal of physiology.

[55]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[56]  L. Ignarro.  Endothelium‐derived nitric oxide: actions and properties , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  Tetsurou Yamamoto,et al.  Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue , 1988, Japanese journal of cancer research : Gann.

[58]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[59]  R. Puri,et al.  Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. , 1988, Journal of the National Cancer Institute.

[60]  R. Weinberg,et al.  A molecular basis of cancer. , 1983, Scientific American.

[61]  A. Gozhenko,et al.  [Role of nitric oxide in tumor growth]. , 2004, Uspekhi fiziologicheskikh nauk.

[62]  Seaver,et al.  Nitric oxide as a secretory product of mammalian cells , 2004 .

[63]  Rakesh K. Jain,et al.  Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.

[64]  R. Jain,et al.  During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. , 1996, Nature medicine.

[65]  H. Granger,et al.  Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. , 1996, The American journal of physiology.

[66]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[67]  G. Tozer,et al.  The influence of nitric oxide on tumour vascular tone. , 1995, Acta oncologica.

[68]  P. López-Jaramillo,et al.  The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.